It should also be noted that this population often uses drugs which can cross-react with FXa inhibitors, such as NSAIDs for cancer pain and macrolide antibiotics for chronic respiratory infections, including Pseudomonas aeruginosa or non-tuberculosis mycobacteria treatment. Here, F10 is linked to tuberculosis.